All Insights
Showing 901 - 912 of 8570
Regulatory Outlook
Environment, social and governance | UK Regulatory Outlook November 2024
Sustainable supply chains drive international success | Autumn Budget 2024 | Updates made to the UK's retail disclosure regime
Regulatory Outlook
Fintech, digital assets, payments and consumer credit | UK Regulatory Outlook November 2024
Third HM Treasury consultation on regulation of BNPL products | FCA blog on cryptoasset businesses registering under MLRs 2017 |
Regulatory Outlook
Food law | UK Regulatory Outlook November 2024
Autumn Budget 2024 | Investigation into mustard products contaminated with peanuts draws to a close | European Court overturns ban
Regulatory Outlook
Health and Safety | UK Regulatory Outlook November 2024
Terrorism (Protection of Premises) Bill completes Commons Committee stage | Higher Risk Buildings: confusion over whether a roof garden counts
Regulatory Outlook
Bribery, fraud and anti-money laundering | UK Regulatory Outlook November 2024
Failure to prevent fraud guidance published
Regulatory Outlook
Competition | UK Regulatory Outlook November 2024
Merger remedies approach to be reviewed | Booking.com removes all parity clause in EEA | UK-EU cooperation agreement
Regulatory Outlook
Artificial Intelligence | UK Regulatory Outlook November 2024
ICO publishes recommendations on use of AI tools in recruitment | EU AI Act: first draft of the General-Purpose AI
Regulatory Outlook
Consumer Law | UK Regulatory Outlook November 2024
Secondary legislation made under Media Act 2024 | Culture, Media and Sport Committee re-launches British film and high-end TV inquiry
Regulatory Outlook
Cyber Security | UK Regulatory Outlook November 2024
ENISA draft technical guidance on NIS2 cyber security risk management measures | DSIT call for evidence on Cyber Security and
Regulatory Outlook
Products | UK Regulatory Outlook November 2024
Product Regulation and Metrology Bill starts committee stage | Wales pulls out of UK-wide Deposit Return Scheme | Government to
Regulatory Outlook
Modern Slavery | UK Regulatory Outlook November 2024
EU Regulation prohibiting products in the Union market made using forced labour receives final approval
Life Sciences and Healthcare
EU enforces stricter liability for life sciences products
Pharma and medtech companies face enhanced liability under the EU's new directive
